Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct;14(10):811-8.
doi: 10.3779/j.issn.1009-3419.2011.10.08.

[Advances on treatment of limited-disease small cell lung cancer]

[Article in Chinese]
Jinghui Wang  1 , Shucai Zhang
Affiliations
Review

[Advances on treatment of limited-disease small cell lung cancer]

[Article in Chinese]
Jinghui Wang et al. Zhongguo Fei Ai Za Zhi. 2011 Oct.
No abstract available

PubMed Disclaimer

References

    1. Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase Ⅲ trial with 5 years' follow-up. J Clin Oncol. 2002;20(24):4665–4672. doi: 10.1200/JCO.2002.12.111. - DOI - PubMed
    1. Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol. 1996;14(3):821–828. doi: 10.1200/JCO.1996.14.3.821. - DOI - PubMed
    1. Jara C, Gomez-Aldaravi JL, Tirado R, et al. Small-cell lung cancer in the elderly-is age of patient a relevant factor? Acta Oncol. 1999;38(6):781–786. doi: 10.1080/028418699432941. - DOI - PubMed
    1. Noguchi T, Mochizuki H, Yamazaki M, et al. A retrospective analysis of clinical outcomes of patients older than or equal to 80 years with small cell lung cancer. J Thora Oncol. 2010;5(7):1081–1087. doi: 10.1097/JTO.0b013e3181de7173. - DOI - PubMed
    1. Caprario LC, Kent DM, Trikalinos TA, et al. Determinants of chemotherapy administration and effects of chemotherapy on survival in elderly patients with small cell lung cancer (SCLC): A SEER-medicare analysis. J Clin Oncol. 2011;29(15_S):7083 [abstract].